Skip to content

Comparison of Evening prime rose oil and vitamin E on reduction of symptom of premenstrual syndrom.

Comparison of Evening prime rose oil and vitamin E on reduction of symptoms of premenstrual syndrom.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013061313405N2
Enrollment
70
Registered
2014-01-06
Start date
2013-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre menstrual syndrom. Unspecified mood [affective] disorder

Interventions

Intervention 1: The intervention group for two consecutive cycles, at least 14 days before menstruation, will receive three capsules of Evening primrose oil therapy (per capsule 1000 mg) in 3 dose d
Treatment - Drugs
The intervention group for two consecutive cycles, at least 14 days before menstruation, will receive three capsules of Evening primrose oil therapy (per capsule 1000 mg) in 3 dose daily and in gro
In control group one capsule of Vitamin E 400 UI daily that similar to prime rose oils capsules in luteal phase of cycle for two months will use.

Sponsors

Vice chancellor for Research the Technology, Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: a) Women in age between 18-30 years old; b) Having regular menstrual cycles every 35-24 days; c) Lack of physical or medication illness; d) No history of mental illness and depression; e) lack of antidepressant use in the past months f) Suffering from premenstrual syndrom. Exclusion study: a) Any use of hormonal and vitamin drugs or contraceptive pills; b) Experience of the spiritual crisis or death of a family member or surgery in the last three months ago.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Physical symptom of pre menstrual syndrom. Timepoint: Before intervention- immediately after intervention- 2 months after intervention. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Mental symptom of pre menstrual syndrom. Timepoint: Before intervention-immediatly after intervention-2 months after intervention. Method of measurement: A questionnaire based on DSM-IV research criteria and demographic questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyedeh Zahra Masoumi

Hamedan University of Medical Sciences

zahramid2001@yahoo.com; zahra.masoomi@umsha.ac.ir+98 81 1838 0150

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026